Session 2: Treatment of Oesophago-Gastric Cancer: Setting the Stage – Who Benefits from Multimodal Therapy
Chairs: Michel Ducreux (France), Paul M. Schneider (Switzerland)
- Magnus Nilsson, Sweden: Which tumours need more treatment than just surgery?
- Angela Riddell, UK: What imaging is needed to select patients for neoadjuvant treatment & where are the limitations?
- Marcel Verheij, The Netherlands: Patterns of recurrence to guide selection of multi-modal treatment?